EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Tamoxifen effects on treatment fibrocystic breast disease in women



Tamoxifen effects on treatment fibrocystic breast disease in women



Saudi Medical Journal 27(4): 565-566




(PDF emailed within 1 workday: $29.90)

Accession: 050499407

Download citation: RISBibTeXText

PMID: 16598346



Related references

Effects of tamoxifen on endometrial estrogen and progesterone receptor concentrations in women with fibrocystic disease of the breast. Gynecological Endocrinology 7(3): 185-189, 1993

Evaluation of danazol treatment of women with fibrocystic disease of breast. Polski Tygodnik Lekarski 44(32-33): 771-773, 1989

Fibrocystic disease of the breast in premenopausal women histohormonal correlation and response to lhrh analog treatment. American Journal of Obstetrics & Gynecology 164(5 PART 1): 1181-1189, 1991

Comparison of tamoxifen and bromocriptine in management of fibrocystic breast disease a randomized blind study. Annals of the New York Academy of Sciences 464(none): 626-628, 1986

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. Journal of the National Cancer Institute 95(4): 302-307, 2003

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer: A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age. Breast Cancer Research & Treatment 61(2): 103-110, 2000

Critical, morphological, and histopathogenic considerations on fibrocystic breast disease; fibrocystic disease and carcinoma of the breast. Archivio Italiano di Anatomia E Istologia Patologica 24(6): 473-514, 1951

Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Research 38(9): 3051-3054, 1978

Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease. Journal of Clinical Laboratory Analysis 13(2): 75-81, 1999

Anastrozol (Ana) versus tamoxifen (Tam) treatment in postmenopausal breast cancer women with tamoxifen treatment and abnormal vaginal bleeding: Results from an open-label randomized trial. Journal of Clinical Oncology 23(16_suppl): 648-648, 2016

Fibrocystic disease of the breast in premenopausal women: histohormonal correlation and response to luteinizing hormone releasing hormone analog treatment. American Journal of Obstetrics and Gynecology 164(5 Pt 1): 1181-1189, 1991

Preliminary results of a randomized study of tamoxifen alone or tamoxifen and breast radiation in women over 50 years of age with T1/2 N0 disease. International Journal of Radiation Oncology Biology Physics 51(3 Supplement 1): 106, 2001

Nutritional profile of women with fibrocystic breast disease. International Journal of Epidemiology 22(6): 989-999, 1993

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 98(9): 1802-1810, 2003